Virtual reality glove for home‐based hand and arm stroke rehabilitation ( vREHAB )
Abstract
Background: Upper extremity impairment is common after stroke. Virtual‐reality rehabilitation systems may help restore hand and arm function. Objective: To assess the feasibility of the Neofect Smart Glove and its effect on functional recovery. Design: Multicenter, prospective, randomized, open‐label, blinded‐endpoint phase 2 trial consisting of a 12‐week active treatment period followed by a 12‐week follow‐up period. Study Population: Patients with subacute and chronic stroke with upper extremity impairment. Interventions: Patients assigned to the intervention group were instructed to use the Smart Glove for a minimum of one session per day for at least 5 days per week during the 12‐week active treatment period, in addition to their usual care. Patients in the control group received their usual care only. Outcomes: Feasibility was assessed by the total dose of rehabilitation. The change from baseline to week 12 on the Jebsen‐Taylor Hand Function Test (JTHFT) was the primary efficacy outcome and the change on the Upper Extremity Fugl‐Meyer Assessment (UE‐FMA) was secondary. Statistics: Differences between treatment arms were compared using analysis of covariance in the overall population and, separately, in a post‐hoc and exploratory analysis consisting of a subset of patients with mild to moderate upper extremity impairment (baseline JTHFT ≤500). Results: During the 12‐week active treatment period, there were no differences between the intervention ( n = 18) and control ( n = 24) groups in the change in the JTHFT (median −64 vs. −69 seconds, p = .88), the change in the UE‐FMA (median 8 vs. 8 points, p = .61), or the total dose of rehabilitation (median 1434 vs. 584 minutes, p = .18). Among the subgroup of patients with mild to moderate symptoms (baseline JTHFT ≤500, n = 31), Smart Glove assignment was associated with a greater improvement on the JTHFT (median −72 vs. −40 seconds, p = .01) and a greater dose of rehabilitation (median 1739 vs. 510 minutes, p = .04) during the active treatment period, but there was no difference in the change in the UE‐FMA (median 10 vs. 8 points, p = .15). Conclusion: The addition of the Smart Glove to traditional rehabilitation therapy did not improve hand and arm function in the overall study population but may increase the dose of rehabilitation and improve hand and arm function for patients with mild to moderate upper extremity impairment.Keywords
This publication has 15 references indexed in Scilit:
- Exploring the transformative influence of neuroplasticity on stroke rehabilitation: a narrative review of current evidenceAnnals of Medicine & Surgery, 2023
- Critical Period After Stroke Study (CPASS): A phase II clinical trial testing an optimal time for motor recovery after stroke in humansProceedings of the National Academy of Sciences of the United States of America, 2021
- Home‐based virtual reality therapy for hand recovery after strokePM&R, 2021
- Virtual reality for stroke rehabilitationCochrane Database of Systematic Reviews, 2017
- Increasing the amount of usual rehabilitation improves activity after stroke: a systematic reviewJournal of Physiotherapy, 2016
- Constraint-induced movement therapy as a rehabilitation intervention for upper extremity in stroke patients: systematic review and meta-analysisInternational Journal of Rehabilitation Research, 2016
- Stroke Severity Is a Crucial Predictor of Outcome: An International Prospective Validation StudyJournal of the American Heart Association, 2016
- Incidence, Time Course and Predictors of Impairments Relating to Caring for the Profoundly Affected arm After Stroke: A Systematic ReviewPhysiotherapy Research International, 2015
- Interventions for improving upper limb function after strokeCochrane Database of Systematic Reviews, 2014
- Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after StrokeNew England Journal of Medicine, 2010